Lanreotide recalls

The FDA has published 3 recalls involving Lanreotide since 2026. The latest was reported on 15 Apr 2026. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2026

Last 12 months3reported

Class I00% of total

Ongoing3latest 15 Apr 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 1Jan '26 0 0 2Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why lanreotide is recalled

Sterility267%
Particulate Matter133%

Companies

Cipla USA3100%

By year

20263100%

Ongoing lanreotide recalls

3 active

Reported	Class	Recall	Company	Reason	Where
15 Apr 2026Drug	CLASS II	Lanreotide Injection, 120 mg* recalled by Cipla USALanreotide Acetate	Cipla USA	Sterility	Nationwide
15 Apr 2026Drug	CLASS II	Lanreotide Injection, 120 mg recalled by Cipla USALanreotide Acetate	Cipla USA	Sterility	Nationwide
21 Jan 2026Drug	CLASS II	Lanreotide Injection, 120 mg/ per pre-filled syringe recalledLanreotide Acetate	Cipla USA	Particulate Matter	Nationwide

All lanreotide recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
15 Apr 2026Drug	CLASS II	Lanreotide Injection, 120 mg* recalled by Cipla USALanreotide Acetate	Cipla USA	Sterility	Nationwide
15 Apr 2026Drug	CLASS II	Lanreotide Injection, 120 mg recalled by Cipla USALanreotide Acetate	Cipla USA	Sterility	Nationwide
21 Jan 2026Drug	CLASS II	Lanreotide Injection, 120 mg/ per pre-filled syringe recalledLanreotide Acetate	Cipla USA	Particulate Matter	Nationwide

Should you stop taking Lanreotide?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.